U.S. Medical Device Outsourcing Market Size & Outlook
The medical device outsourcing market in the United States is expected to reach a projected revenue of US$ 95,762.9 million by 2033. A compound annual growth rate of 13.9% is expected of the United States medical device outsourcing market from 2026 to 2033.
The U.S. medical device outsourcing market generated a revenue of USD 34,406.4 million in 2025 and is expected to reach USD 95,762.9 million by 2033.
The U.S. market is expected to grow at a CAGR of 13.9% from 2026 to 2033.
In terms of segment, cardiology was the largest revenue generating application in 2025.
General & Plastic Surgery is the most lucrative application segment registering the fastest growth during the forecast period.
Medical device outsourcing market data book summary
Market revenue in 2025
USD 34,406.4 million
Market revenue in 2033
USD 95,762.9 million
Growth rate
13.9% (CAGR from 2026 to 2033)
Largest segment
Cardiology
Fastest growing segment
General & Plastic Surgery
Historical data
2021 - 2024
Base year
2025
Forecast period
2026 - 2033
Quantitative units
Revenue in USD million
Market segmentation
Cardiology, Diagnostic imaging, Orthopedic, IVD, Ophthalmic, General & Plastic Surgery, Drug Delivery, Dental, Endoscopy, Diabetes Care, Other Application
Key market players worldwide
SGS AG, Labcorp Holdings Inc, Eurofins Scientific SE, Pace Analytical Services, Intertek Group PLC, Wuxi AppTec Co Ltd, Sotera Health Co Ordinary Shares, Charles River Laboratories International Inc, Medical Device Testing Services, FREYR Battery Inc, PAREXEL, Accell, Genpact Ltd, Criterium Inc., Promedica International, Medpace Holdings Inc, Icon PLC, IQVIA Holdings Inc, Integer Holdings Corp, Tecomet, Jabil Inc, Flex Ltd, Celestica Inc Ordinary Shares (Subordinate Voting), Sanmina Corp, Plexus Corp, Molex, Steris PLC, West Pharmaceutical Services Inc, NAMSA, TUV SUD, RJR Consulting, Mandala International, Global Regulatory Partners, Emergo Group, BioTeknica Engineering & Regulatory Services
Other key industry trends
In terms of revenue, U.S. accounted for 21.8% of the global medical device outsourcing market in 2025.
Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
In North America, U.S. medical device outsourcing market is projected to lead the regional market in terms of revenue in 2033.
Canada is the fastest growing regional market in North America and is projected to reach USD 16,717.7 million by 2033.
The U.S. held the largest market share of 86.54% in North America in 2023. Large medical device companies are outsourcing parts of their regulatory functions, such as report writing & publishing, clinical trial application services, product design, and product maintenance, to regulatory service providers, thereby contributing to the growth of the medical device outsourcing market in the U.S.
These companies are also increasingly inclined toward medical device outsourcing due to the requirement of high maintenance and efficient systems for the management of raw materials, which results in minimizing the overall setup costs.
Moreover, medical device outsourcing helps the company focus on core capabilities, the sharing of associated risks, and improved service delivery, which are pertinent to gaining competitive advantages.
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Medical Device Outsourcing Market Outlook will help companies and investors design strategic landscapes.
Cardiology was the largest segment with a revenue share of 25.9% in 2025.
Horizon Databook has segmented the U.S. medical device outsourcing market based on cardiology, diagnostic imaging, orthopedic, ivd, ophthalmic, general & plastic surgery, drug delivery, dental, endoscopy, diabetes care, other application covering the revenue growth of each sub-segment from 2021 to 2033.
The U.S. held the largest market share of 86.54% in North America in 2023. Large medical device companies are outsourcing parts of their regulatory functions, such as report writing & publishing, clinical trial application services, product design, and product maintenance, to regulatory service providers, thereby contributing to the growth of the medical device outsourcing market in the U.S.
These companies are also increasingly inclined toward medical device outsourcing due to the requirement of high maintenance and efficient systems for the management of raw materials, which results in minimizing the overall setup costs.
Moreover, medical device outsourcing helps the company focus on core capabilities, the sharing of associated risks, and improved service delivery, which are pertinent to gaining competitive advantages.
U.S. Medical Device Outsourcing Market Application Outlook (Revenue, USD Million , 2021-2033)
Cardiology
Diagnostic imaging
Orthopedic
IVD
Ophthalmic
General & Plastic Surgery
Drug Delivery
Dental
Endoscopy
Diabetes Care
Other Application
U.S. Medical Device Outsourcing Market Services Outlook (Revenue, USD Million , 2021-2033)
Quality Assurance Services
Regulatory Consulting Services
Product Design & Development Services
Product Testing & Sterilization Services
Product Implementation Services
Product Upgrade Services
Product Maintenance Services
Contract Manufacturing Services
U.S. Medical Device Outsourcing Market Class Type Outlook (Revenue, USD Million , 2021-2033)
Class I
Class II
Class III
Reasons to subscribe to Medical Device Outsourcing Market Outlook databook
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Medical Device Outsourcing Market Outlook databook
Our clientele includes a mix of Medical Device Outsourcing Market Outlook companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. Medical Device Outsourcing Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into U.S. Medical Device Outsourcing Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
U.S. Medical Device Outsourcing Market, 2021-2033 (US$M)